Novavax Inc. (NVAX)
NASDAQ · Healthcare
Novavax Inc. EBITDA 2010–2025
Novavax Inc. annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Novavax Inc. ebitda for the quarter ending March 31, 2026 was -12.4 M, a 102.36% decrease year-over-year.
- Novavax Inc. ebitda for the twelve months ending March 31, 2026 was 75.1 M, a 248.62% decrease year-over-year.
- Novavax Inc. annual ebitda for 2025 was 480.8 M, a 339.28% decrease from 2024.
- Novavax Inc. annual ebitda for 2024 was -200.9 M, a 61.76% decrease from 2023.
- Novavax Inc. annual ebitda for 2023 was -525.5 M, a 14.65% decrease from 2022.
- Novavax Inc. annual ebitda for 2022 was -615.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Novavax Inc. EBITDA — FAQ
Novavax Inc. (NVAX) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVAX's ebitda history?
The chart and table above show Novavax Inc.'s ebitda by year and by quarter, including the growth rate.